Rosetta Genomics (ROSG +15% to $5.44) flies after Aegis Capital initiates coverage of the shares...

|About: Rosetta Genomics Ltd. (ROSG)|By:, SA News Editor

Rosetta Genomics (ROSG +15% to $5.44) flies after Aegis Capital initiates coverage of the shares with a "buy" rating and gives them an eye-catching price target of $16. Shares also spiked sharply on Monday after Rosetta announced management hires.